Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01. Entry into a Material Definitive
Agreement.
On February 12, 2026, D.
Boral Acquisition I Corp. (the “Company”) consummated its initial public offering (“IPO”), which
consisted of 28,750,000 units (the “Units”), including the exercise in full by the underwriter of an option to purchase
up to 3,750,000 Units at the offering price to cover over-allotments. The Units were sold at a price of $10.00 per Unit, generating gross
proceeds to the Company of $287,500,000. Each Unit consists of one Class A ordinary share, par value $0.0001 per share (the “Class
A Ordinary Shares”), of the Company, and one-half of one redeemable warrant (each, a “Warrant”) of the Company,
with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share.
In connection with the IPO,
the Company entered into the following agreements, forms of which were previously filed as exhibits to the registration statement on Form
S-1 relating to the IPO (the “Registration Statement”):
An Underwriting Agreement,
dated February 10, 2026, by and between the Company and D. Boral Capital LLC (the “Representative”) and the qualified
independent underwriter named therein, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.
A Warrant Agreement, dated
February 10, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is
attached as Exhibit 4.1 hereto and incorporated herein by reference.
An Investment Management Trust
Agreement, dated February 10, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy
of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.
A Registration Rights Agreement,
dated February 10, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto and
incorporated herein by reference.
A Private Placement Units Purchase
Agreement, dated February 10, 2026 (the “Sponsor Private Placement Units Purchase Agreement”), by and between the
Company and D. Boral Sponsor I LLC (the “Sponsor”), a copy of which is attached as Exhibit 10.3 hereto and incorporated
herein by reference.
A Letter Agreement, dated February
10, 2026, by and among the Company, its officers, its directors and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and
incorporated herein by reference.
An Administrative Services
Agreement, dated February 10, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and
incorporated herein by reference.
Indemnity Agreement, dated
February 10, 2026, by and among the Company and each Director (as defined below) and executive officers of the Company, a copy of form
of which is attached as Exhibit 10.6 hereto and incorporated herein by reference.
Item 3.02Item 3.02 - Unregistered Sales of Equity
Item 3.02. Unregistered Sales of Equity
Securities.
Simultaneously with the closing
of the IPO, pursuant to the Private Placement Units Purchase Agreement, the Company completed the private placement of an aggregate of
200,000 units (the “Private Placement Units”) to the Sponsor at $10.00 per Unit, each Unit consisting of one Class
A Ordinary Share and one-half of one redeemable Warrant, each whole Warrant exercisable to purchase one Class A Ordinary Share of the
Company. The Warrants contained in the Private Placement Units are identical to the Warrants included in the Units sold in the IPO, except
as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The
issuance of the Private Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities
Act of 1933, as amended.
The Company also issued
to the Representative and/or its designees, 2,000,000 Class A ordinary shares upon the consummation of the IPO (the “Representative
Shares”). The Representative Shares are identical to the Class A Ordinary Shares included in the Units, except that
these securities cannot be sold, transferred, assigned, pledged or hypothecated or the subject of any hedging, short sale,
derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of
180 days from the date of the IPO except as permitted under FINRA Rule 5110(e)(2). The Representative agreed not to transfer, assign
or sell any such shares until the completion of the Company’s initial business combination without the Company’s written
consent. In addition, the Representative agreed (i) to waive its redemption rights with respect to such shares in connection with
the completion of the Company’s initial business combination and (ii) to waive its rights to liquidating distributions from
the trust account with respect to such shares if the Company fails to complete its initial business combination within the period of
time provided in the Amended and Restated Memorandum and Articles of Association (as defined below). The issuance of the
Representative Shares was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of
1933, as amended.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 10, 2026, in
connection with the IPO, Luisa Ingargiola, Jeffrey Tullman, George Kollitides, and Kevin McGurn (the “New Directors”
and, collectively with David Boral, John Darwin, and Benjamin Piggott the “Directors” and each singularly a “Director”)
were appointed to the board of directors of the Company (the “Board”). Effective February 10, 2026, each of Luisa Ingargiola,
George Kollitides and Jeffrey Tullman were appointed to the Board’s Audit Committee with Luisa Ingargiola serving as chair of the
Audit Committee. Each of George Kollitides, Jeffrey Tullman, and Kevin McGurn were appointed to the Board’s Compensation Committee,
with George Kollitides serving as chair of the Compensation Committee.
On February 10, 2026, the
Company entered into indemnity agreements with each of its Directors and officers that require the Company to indemnify each of them to
the fullest extent permitted by applicable law and to advance expenses incurred as a result of any proceeding against them as to which
they could be indemnified. The foregoing summary of the indemnity agreements does not purport to be complete and is subject to, and qualified
in its entirety by, the full text of the form of indemnity agreement, which is filed as Exhibits 10.6 to this Current Report on Form 8-K
and incorporated in this Item 5.02 by reference.
Item 5.03Item 5.03 - Amendments to Articles/Bylaws
Item 5.03. Amendments to Certificate
of Incorporation or Bylaws; Change in Fiscal Year.
On February 10, 2026, in
connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and
Restated Memorandum and Articles of Association”) with the BVI Registrar of Corporate Affairs, which was effective on February
10, 2026. The terms of the Amended and Restated Memorandum and Articles of Association are set forth in the Registration Statement and
are incorporated herein by reference. A copy of the Amended and Restated Memorandum and Articles of Association is attached as Exhibit
3.1 hereto and incorporated herein by reference.
Item 8.01. Other Events.
A total of $287,500,000,
comprised of the proceeds from the IPO and the sale of the Private Placement Units, was placed in a U.S.-based trust account maintained
by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds in the trust
account that may be released to the Company to pay its taxes and for winding up and dissolution expenses, the funds held in the trust
account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination,
(ii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 18 months
from the closing of the IPO (or 21-month period if the Sponsor exercises its three month-extension option) (or by such earlier liquidation
date as the Company’s board of directors may approve), subject to applicable law, and (iii) the redemption of the Company’s
public shares properly submitted in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and
Articles of Association to modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it
has not consummated an initial business combination within 18 months from the closing of the IPO (or 21-month period if the Sponsor exercises
its three month-extension option) or with respect to any other material provisions relating to shareholders’ rights or pre-initial
business combination activity.
On February 10, 2026, the
Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on
Form 8-K.
On February 12, 2026, the
Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on
Form 8-K.
Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events.
A total of $287,500,000,
comprised of the proceeds from the IPO and the sale of the Private Placement Units, was placed in a U.S.-based trust account maintained
by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds in the trust
account that may be released to the Company to pay its taxes and for winding up and dissolution expenses, the funds held in the trust
account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination,
(ii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 18 months
from the closing of the IPO (or 21-month period if the Sponsor exercises its three month-extension option) (or by such earlier liquidation
date as the Company’s board of directors may approve), subject to applicable law, and (iii) the redemption of the Company’s
public shares properly submitted in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and
Articles of Association to modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it
has not consummated an initial business combination within 18 months from the closing of the IPO (or 21-month period if the Sponsor exercises
its three month-extension option) or with respect to any other material provisions relating to shareholders’ rights or pre-initial
business combination activity.
On February 10, 2026, the
Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on
Form 8-K.
On February 12, 2026, the
Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on
Form 8-K.